Study of the Combination of Apatinib and POF
- First Posted Date
- 2018-10-16
- Last Posted Date
- 2018-10-16
- Lead Sponsor
- Fujian Cancer Hospital
- Target Recruit Count
- 26
- Registration Number
- NCT03707639
- Locations
- 🇨🇳
Rongbo Lin, Fuzhou, Fujian, China
Nimotuzumab for Recurrent Nasopharyngeal Carcinoma
- First Posted Date
- 2018-09-11
- Last Posted Date
- 2018-09-11
- Lead Sponsor
- Fujian Cancer Hospital
- Target Recruit Count
- 67
- Registration Number
- NCT03666221
- Locations
- 🇨🇳
Department of radiation oncology, Fujian cancer hospital, Fuzhou, Fujian, China
EBV-TCR-T（YT-E001）for Patients With EBV-positive Recurrent or Metastatic NPC
Phase 2
- Conditions
- Nasopharyngeal Carcinoma
- Interventions
- Biological: EBV-TCR-T (YT-E001) cells
- First Posted Date
- 2018-08-27
- Last Posted Date
- 2020-08-11
- Lead Sponsor
- Fujian Cancer Hospital
- Target Recruit Count
- 20
- Registration Number
- NCT03648697
- Locations
- 🇨🇳
Fujian Cancer Hospital, Fuzhou, Fujian, China
Cognitive Dysfunction in Patients With Cancer Pain
- Conditions
- Cognitive Dysfunction
- First Posted Date
- 2018-08-22
- Last Posted Date
- 2018-08-22
- Lead Sponsor
- Fujian Cancer Hospital
- Target Recruit Count
- 928
- Registration Number
- NCT03641820
- Locations
- 🇨🇳
Department of Nursing, Fujian Provincial Cancer Hospital, Fuzhou, Fujian, China
Change the Dose Frequency of Controlled-Release Oxycodone to Refractory Pain
Phase 4
Withdrawn
- Conditions
- Cancer Pains
- Interventions
- Drug: Increasing the Controlled-Release Oxycodone dose frequency
- First Posted Date
- 2018-08-21
- Last Posted Date
- 2021-03-08
- Lead Sponsor
- Fujian Cancer Hospital
- Registration Number
- NCT03639415
Phase I Study of the Combination of Anlotinib With Pemetrexed or Docetaxel
Not Applicable
- Conditions
- Non-squamous Non-small Cell Lung Cancer
- Interventions
- First Posted Date
- 2018-06-25
- Last Posted Date
- 2018-06-25
- Lead Sponsor
- Fujian Cancer Hospital
- Target Recruit Count
- 18
- Registration Number
- NCT03566576
Appaconitine Patch for Oral Mucositis Pain Caused by Chemoradiotherapy in Patients With Nasopharyngeal Cancer
Not Applicable
- Conditions
- Radiation Induced Oral Mucositis
- Interventions
- Drug: standard care
- First Posted Date
- 2018-05-08
- Last Posted Date
- 2018-05-14
- Lead Sponsor
- Fujian Cancer Hospital
- Target Recruit Count
- 74
- Registration Number
- NCT03518489
- Locations
- 🇨🇳
Fujian Cancer Hospital Radiation Oncology Department, Fuzhou, Fujian, China
Gefitinib and Berberine in the First-line Treatment of Lung Adenocarcinoma With EGFR Mutation
- First Posted Date
- 2018-04-03
- Last Posted Date
- 2018-04-03
- Lead Sponsor
- Fujian Cancer Hospital
- Target Recruit Count
- 50
- Registration Number
- NCT03486496
- Locations
- 🇨🇳
Fujian cancer hospital, Fuzhou, Fujian, China
Afatinib Plus Chemotherapy Against Esophageal or Lung Squamous Cell Carcinoma
- First Posted Date
- 2018-04-03
- Last Posted Date
- 2018-04-03
- Lead Sponsor
- Fujian Cancer Hospital
- Target Recruit Count
- 2
- Registration Number
- NCT03486509
Next-generation Sequencing in Gastrointestinal Cancer
- Conditions
- Gastrointestinal Cancer
- Interventions
- Diagnostic Test: Device： NGS sequencing cfDNA
- First Posted Date
- 2018-03-23
- Last Posted Date
- 2018-07-02
- Lead Sponsor
- Fujian Cancer Hospital
- Target Recruit Count
- 200
- Registration Number
- NCT03476057
- Locations
- 🇨🇳
Rongbo Lin, Fuzhou, Fujian, China
© Copyright 2025. All Rights Reserved by MedPath